ResMed outlines 61%–63% gross margin target for FY26 while ramping up share buybacks and dividend ResMed outlines 61%–63% gross margin target for FY26 while ramping up share buybacks and dividend Post Contentrmd, rsmdfRead More You might also be interested in reading Yum China declares $0.24 dividend. August 1, 2025 In Mainstream ← Previous post Next post →